Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1

SIMPLE SUMMARY: Medulloblastoma is the most common malignant childhood brain tumor and it is considered poor immunogenic because of its low mutational burden. Nevertheless, several clinical trials are currently evaluating immunotherapy for medulloblastoma patients, since new treatment strategies for...

Descripción completa

Detalles Bibliográficos
Autores principales: Paret, Claudia, Lehmann, Nadine, Bender, Hannah, Sprang, Maximilian, Sommer, Clemens J., Cana, Denis, Seidmann, Larissa, Wingerter, Arthur, Neu, Marie A., El Malki, Khalifa, Alt, Francesca, Roth, Lea, Marini, Federico, Ottenhausen, Malte, Glaser, Martin, Knuf, Markus, Russo, Alexandra, Faber, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616194/
https://www.ncbi.nlm.nih.gov/pubmed/34830991
http://dx.doi.org/10.3390/cancers13225838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616194/
https://www.ncbi.nlm.nih.gov/pubmed/34830991
http://dx.doi.org/10.3390/cancers13225838

Ejemplares similares